ASG Superconductors with HZDR researchers combine magnetic resonance imaging with particle beams
ASG Superconductors with researchers of the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) will build the world’s first prototype that tracks moving tumors with magnetic resonance imaging (MRI) in real time during proton therapy. They are combining a rotating open MRI device for the LINAC-MR system Alberta Health Services, with an actively scanned clinical-akin proton beam at OncoRay, the Dresden-based National Center for Radiation Research in Oncology. The rotating MRI device is produced by ASG Superconductors, using the MROpen Evo technology-based helium-free superconducting magnesium diboride (MgB2) magnet. Real-time MRI would make it possible to synchronize the proton beam to tumor motion during radiation dose delivery. So far, this has been impossible and therefore was a limiting factor for treating moving tumors with this promising cancer therapy.
NEWS
Dr. Simon Blease – Imaging Director – European Scanning Centre – London (UK)
“…it sounds obvious, but it is better to scan [...]
Another MROpen Evo ready for the shipment to North America
Another MROpenEvo system is on its way to North America. [...]
Opening the horizon of imaging
MROpen Evo allow special studies & research. Greatest versatility enables [...]
Do you know why MROpen EVO is so special?
Heather Mason, our RT (MR) Applications Specialist, will discuss [...]
Video: the world’s only OPEN SKY Upright MRI
Discover MROpen EVO features, technology and innovation in the [...]
An in vivo study exploring correlations between early‑to‑moderate disc degeneration and flexion mobility in the lumbar spine
Early disc degeneration (DD) has been thought to be [...]
DISCOVER MORE